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Objectives: To identify b-lactamase genes in gut commensal Bacteroides species and to assess the impact
of these enzymes, when carried by outer membrane vesicles (OMVs), in protecting enteric pathogens and
commensals.
Methods: A deletion mutant of the putative class A b-lactamase gene (locus tag BT_4507) found in the genome
of the human commensal Bacteroides thetaiotaomicron was constructed and a phenotypic analysis performed.
A phylogenetic tree was built from an alignment of nine Bacteroides cephalosporinase protein sequences, using
the maximum likelihood method. The rate of cefotaxime degradation after incubation with OMVs produced by
different Bacteroides species was quantified using a disc susceptibility test. The resistance of Salmonella
Typhimurium and Bifidobacterium breve to cefotaxime in liquid culture in the presence of B. thetaiotaomicron
OMVs was evaluated by measuring bacterial growth.
Results: The B. thetaiotaomicron BT_4507 gene encodes a b-lactamase related to the CepA cephalosporinase of
Bacteroides fragilis. OMVs produced by B. thetaiotaomicron and several other Bacteroides species, except
Bacteroides ovatus, carried surface-associated b-lactamases that could degrade cefotaxime. b-Lactamase-
harbouring OMVs from B. thetaiotaomicron protected Salmonella Typhimurium and B. breve from an otherwise
lethal dose of cefotaxime.
Conclusions: The production of membrane vesicles carrying surface-associated b-lactamases by Bacteroides
species, which constitute a major part of the human colonic microbiota, may protect commensal bacteria
and enteric pathogens, such as Salmonella Typhimurium, against b-lactam antibiotics.
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Introduction
The adult human gastrointestinal (GI) tract accommodates a bac-
terial community (the microbiota) comprising trillions of cells that
carry out vital functions for human health. This association involves
co-evolved beneficial human–microbiota interactions that are
altered as a result of many environmental factors. In particular,
the presence of antibiotics can disturb colonic metabolism and
absorption of vitamins, and can alter susceptibility to infection.1,2
The human GI tract microbiota is dominated by two bacterial
phyla, Firmicutes and Bacteroidetes.3 Species of the genus
Bacteroides, which constitute 30% of all bacteria in the human
GI tract, are among the most resistant anaerobes to antibiotics,4
including penicillins and broad-spectrum cephalosporins.5
During the 1980s, b-lactamase-producing strains of Bacteroides
species were reported to protect penicillin-susceptible b-haemolytic
streptococci from penicillin G in vivo, as shown by monitoring the
formation of subcutaneous abscesses in mice co-infected by both
organisms.6 Likewise, b-lactamases produced by Escherichia coli
can protect Salmonella Typhimurium when both organisms are
co-cultured in liquid broth in the presence of ampicillin.7 It was
suggested in this study that the b-lactamase protected the
Salmonella against ampicillin once it was exported in outer mem-
brane vesicles (OMVs) produced and released into the medium by
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the E. coli strain. Schaar et al.8,9 later confirmed this idea by demon-
strating that b-lactamases associated with OMVs produced by
Moraxella catarrhalis protect Streptococcus pneumoniae and
Haemophilus influenzae against amoxicillin, and that OMVs pro-
duced by H. influenzae could protect group A streptococci against
amoxicillin. The possibility that OMVs produced by commensal
Bacteroides species possess similar capabilities has not been
considered.
In this study, we describe a novel cephalosporinase gene in the
genome of a prominent member of the human GI tract micro-
biota, Bacteroides thetaiotaomicron. Homologues of this gene
exist in most, if not all Bacteroides species. We also describe
the protective effect of b-lactamase-carrying OMVs produced
by B. thetaiotaomicron on the susceptibility of Salmonella
Typhimurium and Bifidobacterium breve to b-lactam antibiotics.
Materials and methods
Bacterial strains and growth conditions
Bacteroides species and strains (Table 1) were grown under anaerobic con-
ditions at 378C in brain heart infusion (BHI) medium (Oxoid/Thermo Fisher,
Basingstoke, UK) supplemented with 0.5 mg/L haemin (Sigma-Aldrich,
St Louis, MO, USA) (BHI–haemin). Antibiotic resistance markers in
B. thetaiotaomicron were selected using 1 mg/L tetracycline, 5 mg/L
erythromycin or 200 mg/L gentamicin. E. coli strains GC10 (Sigma-
Aldrich) transformed with pGH014-based plasmids (see below) and
HB101(pRK2013) (DMSZ Collection, Braunschweig, Germany) were grown
under agitation at 378C in LB medium10 supplemented with 100 mg/L
spectinomycin and 50 mg/L kanamycin, respectively. Electrocompetent
E. coli cells were prepared and transformed by the method of Sambrook
and Russell (2001).10 Salmonella enterica serovar Typhimurium ATCC
14028 was grown at 378C in LB medium under agitation.
Electron microscopy
Samples were fixed for 1 h in 2.5% glutaraldehyde in 0.1 M piperazine-
diethanesulfonic acid (PIPES) buffer (pH 7.2). After washing with 0.1 M
PIPES buffer, each sample was pipetted onto the centre of a small square
of filter paper, which was folded and inserted into a critical-point drying
capsule and dehydrated in a series of ethanol solutions (10, 20, 30, 40,
50, 60, 70, 80, 90 and 3×100%). Samples were critical-point dried in a
Polaron E3000 drier (Quorum Technologies, Newhaven, UK) using liquid
carbon dioxide as the transition fluid. The parcels were then carefully
unfolded and the dry cells attached to sticky tabs mounted on scanning
electron microscopy stubs by flicking the back of the filter paper in the dir-
ection of the stub. The samples were coated with gold in a high-resolution
sputter-coater apparatus (Agar Scientific, Stansted, UK). Scanning electron
microscopy was carried out using a Zeiss Supra 55 VP FEG SEM operating
at 3 kV.
For negative staining, a drop of vesicle suspension was applied to a
carbon-coated Formvar copper grid and left for 1 min before washing
with five or six drops of 2% uranyl acetate solution in water. The excess
stain was wicked off and the grids were left to dry thoroughly before view-
ing in the transmission electron microscope. The grids were examined and
imaged in an Tecnai G2 20 Twin transmission electron microscope (FEI,
Hillsboro, OR, USA) at 200 kV.
Oligonucleotide primers
The primers used are detailed in Table S1 (available as Supplementary data
at JAC Online).
Construction of a BT_4507 deletion mutant
A 798 bp chromosomal DNA fragment upstream from BT_4507 and
including the first 18 nucleotides of its 5′-end region was amplified by
PCR using the primer pair BT4507_1 and BT4507_2. This product
was then cloned into the SacI/BamHI site of the E. coli–Bacteroides
suicide shuttle vector pGH014, consisting of plasmid pFD51611 with
the tetracycline resistance gene tetQ from the Bacteroides plasmid
pBT-212 inserted into the BamHI and SalI restriction sites. A 829 bp
chromosomal DNA fragment downstream from BT_4507, including
the last 46 nucleotides of the 3′-end region, was amplified by PCR
using the primer pair BT4507_3 and BT4507_4 and was cloned into the
SalI/PstI site of the pGH014-based plasmid. The resulting plasmid, con-
taining the BT_4507::tetQ construct, was mobilized from E. coli GC10
into B. thetaiotaomicron by triparental filter mating,13 using E. coli
HB101(pRK2013) as the helper strain. Transconjugants were selected on
BHI–haemin agar containing 200 mg/L gentamicin and 1 mg/L tetracyc-
line. Determination of susceptibility to either tetracycline or erythromycin
was carried out to identify recombinants that were tetracycline resistant
and erythromycin susceptible, after re-streaking transconjugant bacteria
on LB agar containing tetracycline or both antibiotics. PCR analysis and
sequencing were used to confirm the allelic exchange. A transconjugant,
Table 1. Bacteroides species and strains
Strain Origin Locus taga
Combined disc
method (mm)c
ESBL Etestd (cefotaxime/cefotaxime
plus clavulanic acid in mg/L)
B. thetaiotaomicron VPI-5482 (NCTC
10582, Werner, 1970)
DSMZ BT_4507 14+0.8 .16/1
B. thetaiotaomicron GH221 this work DBT_4507 no difference 0.75/0.75
B. dorei DSM 17855 DSMZ BACDOR_02757 9+3.5 16/1
B. fragilis NCTC 9343 (Garrod, 1955) DSMZ BF_1199 12.6+1.7 16/0.75
B. ovatus V975 Whitehead and Hespell44 BACOV975_02528b 18+0.8 16/0.19
B. stercoris DMS 19555 DSMZ BACSTE_01456 7+0.8 .16/1
B. xylanisolvens XB1A ATCC 43183 DSMZ GIB_3495 21.5+0.5 .16/0.125
aThe protein sequences were obtained from the National Center for Biotechnology Information (NCBI) protein databases.
bU. Wegmann, Institute of Food Research, Norwich, UK, personal communication.
cDifference between inhibition zones with cefpodoxime (10 mg) in the presence/absence of clavulanic acid (1 mg). The results shown are from three
experiments performed independently.
dEtests were performed using strips containing cefotaxime and cefotaxime plus clavulanic acid.
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GH221, containing the BT_4507::tetQ construct inserted into the
B. thetaiotaomicron chromosome was selected for further studies.
Overexpression of BT_4507 in the deletion mutant
To complement the B. thetaiotaomicron BT_4507 deletion mutant GH221,
a derivative of the Bacteroides vector pGH043,14 was engineered for high-
level expression of BT_4507. First, the primer pair Lactamase_F and
Lactamase_EcoRI_R was used to amplify an 889 bp region encoding
BT_4507 from B. thetaiotaomicron VPI-5482 genomic DNA. This BT_4507
fragment was digested with EcoRI before cloning into the NcoI (blunted)/
EcoRI site of the Bacteroides expression vector pGH043, creating pGH092.
To visualize the BT_4507 protein by fluorescence imaging, we made an
in-frame fusion of the flavin mononucleotide-based fluorescent protein
Pp1 with the C-terminus of BT_4507, using a 30-amino-acid linker. A
PCR fragment of Pp1 was then obtained, using pGLOW-Pp1-stop
(Evocatal GmbH, Dusseldorf, Germany) plasmid DNA as template. This
fragment, attached to the linker by recombinant PCR, was cloned into
the BsaAI/EcoRI site of pGH092, creating pGH095. To achieve overexpres-
sion, the ribosome-binding site region present in pGH095 was exchanged
with the ribosome-binding site region of vector pGH090,14 by way of splice
extension PCR. Initially, the primer pairs Reverse and 20-Lact_R, and
20-Lact_F and Lactamase_EcoRI_R were used, respectively, on templates
pGH090 and pGH092. The resulting products were then used as templates
for the splice PCR involving the primer pair Reverse and Lactamase_EcoRI_R.
The 683 bp SphI, PshAI-digested PCR fragment was used to replace the
corresponding 761 bp digest fragment of pGH095, creating pGH098.
Transformation of the BT_4507 deletion mutant GH221 with pGH098
resulted in the creation of GH274.
Phylogenetic analysis
The evolutionary relationship of b-lactamases was inferred using the max-
imum likelihood method in the MEGA5 software tool.15 Amino acid
sequences were aligned with PRANK,16 and highly variable regions
removed from the dataset. The Whelan and Goldman model of evolu-
tion17 was used and initial tree(s) for the heuristic search were obtained
automatically as follows. When the number of common sites was
,100, or otherwise less than one-fourth of the total number of sites,
the maximum parsimony method was used; otherwise the BIONJ
method,18 with maximum composite likelihood (MCL) distance matrix,
was used.19 To provide statistical support for each node on the tree, a con-
sensus tree was generated from 1000 bootstrap datasets.
OMV isolation
Bacterial cultures (20 mL) were centrifuged at 5000 g for 15 min at 48C
and the supernatants were filtered through 0.22 mm pore-size polyether-
sulfone (PES) membranes (Sartorius, Goettingen, Germany) to remove
debris and cells. Supernatants were concentrated by ultrafiltration
(100 kDa molecular weight cut-off, Vivaspin 20, Sartorius) to 200 mL.
The retentate was rinsed twice with 20 mL of PBS (pH 7.4) and concen-
trated to 200 mL (2 mg dry weight vesicles). OMV sterility was examined
by checking for growth of any contaminating bacterial cells on
BHI–haemin agar. OMV protein content was determined using the Total
Protein Micro protein assay reagent kit (Sigma-Aldrich) after disruption
by sonication. Alternatively, the dry weight of OMVs was determined
after incubating OMV suspensions in a drying oven for 48 h. OMVs
were also collected from the lower compartment of a Steritop filtration
unit (Millipore, Billerica, USA) containing sterile BHI –haemin medium
on a magnetic stir plate, after their diffusion through a 0.22 mm
pore membrane from the upper compartment containing a growing
B. thetaiotaomicron culture in BHI–haemin. The sterility of the
BHI–haemin containing the vesicles was confirmed by plating OMV sus-
pensions onto BHI–haemin agar immediately before collection.
Measurement of b-lactamase activity
Bacteroides species were grown in 20 mL of BHI–haemin for 16 h, centri-
fuged at 3500 g for 10 min and the periplasmic fraction was prepared
according to the method described by Osborn et al.20 Briefly, the cell pellet
was resuspended in 4 mL of fractionation buffer (30 mM Tris, 20% sucrose,
1 mM EDTA, pH 8) and incubated for 10 min at 208C, then centrifuged for
10 min at 3000 g. This pellet was resuspended in 0.8 mL of ice-cold 5 mM
MgSO4 and left on ice for 10 min, releasing an osmotic shock fluid, which
was separated by centrifugation for 10 min at 3000 g, 48C. OMV concen-
trations were adjusted according to the protein concentrations obtained
after sonication.
To assess the BtCepA b-lactamase activity, 5 mL of protein extract
(corresponding to 5 mg for the vesicles) was added to 95 mL of phosphate
buffer (0.1 M phosphate/1 mM EDTA, pH 7.0) and assayed spectrophoto-
metrically at 486 nm by hydrolysis of 50 mg/L nitrocefin according to
the manufacturer’s instructions (Calbiochem).
Enzyme activity at the surface of OMVs
A suspension of 250 mg of vesicles in 0.1 M phosphate/1 mM EDTA buffer
(pH 7.0) was incubated for 5 min (for vesicles from B. thetaiotaomicron)
and 1 h (for all other Bacteroides species) at 378C in the presence of
100 mg/L proteinase K (Sigma-Aldrich). Proteinase K activity was stopped
by addition of 1 mM phenylmethanesulfonyl fluoride (PMSF). To measure
b-lactamase activity, 50 mg/L nitrocefin was added and changes in
absorbance at 486 nm were measured. For BtMinpp activity, 1 mM inositol
hexakisphosphate (InsP6) (Merck, Readington, NJ, USA) was added to the
OMVs and the mix was incubated for 1 h at 378C. Inositol phosphates were
resolved by anion exchange chromatography as previously described.21 As
a control, 25 mg/L of purified His-tagged BtMinpp was incubated21 with or
without 100 mg/L proteinase K for 1 h at 378C, with 1 mM PMSF added to
stop the reaction. Degradation of 1 mM InsP6 was measured by HPLC
(method described in Stentz et al.21) after incubation for 1 h at 378C.
BtMinpp activity was quantified as the ratio of the sum of the integrated
peak areas of InsP5 products to the sum of the integrated InsP5 and
InsP6 peaks.
b-Lactamase activity in OMVs from multiple Bacteroides
species
For OMV production, the different Bacteroides species were grown in the
presence of 10 mg/L cefotaxime to ensure optimized cephalosporinase
expression. Vesicles corresponding to 10 mg of total protein obtained by
sonication were added to 100 mL of a 10 mg/L cefotaxime solution. The
antibiotic solution containing OMVs was incubated for 1 h at 378C, with
OMVs subsequently removed by filtration (Amicon Ultra-0.5 centrifugal fil-
ter device, 100 kDa, Millipore, Billerica, MA, USA), and 10 mL of filtrate (cor-
responding to 0.1 mg of cefotaxime) was applied to a disc previously
placed on a Salmonella-inoculated soft agar overlay plate. The inhibition
zones were measured after 16 h of incubation at 378C.
Susceptibility tests
The susceptibility of Bacteroides to cefpodoxime and cefpodoxime plus
clavulanic acid was tested using a cefpodoxime combination disc kit
(Oxoid/Thermo Fisher, Basingstoke, UK) with the discs placed on BHI
agar plates topped with a soft agar layer (0.75% agar) seeded with
Bacteroides species. Double-ended Etestw strips (AB bioMe´rieux,
Marcy-l’E´toile, France) containing gradients of cefotaxime (16–0.25 mg/L)
at one end and cefotaxime (1–0.016 mg/L) plus clavulanic acid at the
other end were used to measure susceptibility, on BHI agar. The different
Bacteroides species used were pre-grown in the presence of 5 mg/L cefotax-
ime and the cells were rinsed with fresh BHI broth.
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OMV–Salmonella and OMV–Bifidobacterium
co-incubations
Cultures of S. enterica serovar Typhimurium strain ATCC 14028 and B. breve
UCC2003,22 were grown for 16 h at 378C under agitation in LB broth and
anaerobically in BHI broth supplemented with 0.5% yeast extract (BHIY),
respectively. Aliquots of 10 mL of 100-fold dilutions of these cultures were
added to 10 mL of pre-warmed LB or BHIY, respectively. OMVs from a
20 mL culture of B. thetaiotaomicron (corresponding to 20 mg of total pro-
tein) were concentrated, rinsed and re-suspended in PBS. OMV concentra-
tions were adjusted according to the protein concentrations measured
after sonication. After addition of different concentrations of cefotaxime
the Salmonella culture was incubated at 378C with agitation (250 rpm)
and the Bifidobacterium culture was incubated anaerobically while being
stirred at 378C. At varying times thereafter cells were plated for viable
counts.
Results
BT_4507 encodes a b-lactamase that confers resistance
to high levels of ampicillin
To determine whether OMVs produced by B. thetaiotaomicron har-
bour b-lactamase activity, we first identified the gene(s) respon-
sible for the resistance of the bacterium to b-lactam antibiotics.
We began by measuring the resistance of B. thetaiotaomicron
VPI-5482 to penicillins, observing high-level resistance to
the penicillin derivative ampicillin (Table 2). We also noted that
B. thetaiotaomicron grown in the presence of sublethal concentra-
tions of ampicillin (10–25 mg/L) gave rise to large numbers of
tangled filaments .150 mm long (Figure 1b), comprising non-
septate cells 12.5 mm in length. In considering the distance
between two nodes (Figure 1c), representing the site of cell sept-
ation in normal conditions, this dimension is .10-fold greater
than that of non-treated cells (Figure 1a). Examples of filament
formation in Bacteroides species grown with subinhibitory con-
centrations of b-lactam antibiotics have previously been
reported.23 For E. coli and other Gram-negative aerobes,24,25
the binding of b-lactam antibiotics to PBP3, a key element of
the cell-septation machinery, prevents cell division and leads to
the formation of filamentous cells.
The genome of B. thetaiotaomicron VPI-5482 (NCTC 10582)26
contains four putative b-lactamase genes: three putative class B3
metallo-b-lactamase (MBL) genes (locus tags BT_0822, BT_1146
and BT_1410) and a class A serine b-lactamase gene (BT_4507).
There is, however, a significant risk in naming these gene products
as class B3 MBLs because of their sequence and structural hom-
ology to e.g. metallo-glyoxylases II (based on pairwise sequence
alignments using BLASTP,27 and protein structure alignments per-
formed with 3D-JIGSAW28).29 In addition, because of the suscep-
tibility of the strain and the genus Bacteroides as a whole to
carbapenems, we concluded that MBLs were not a significant fac-
tor in resistance and focused our attention on the serine
b-lactamase. The BT_4507-encoded b-lactamase protein con-
tains a predicted secretion signal (http://www.cbs.dtu.dk/
services/SignalP/), implying that this enzyme is potentially
secreted into the periplasm and could subsequently be packaged
into OMVs, as shown for other bacterial species.30 We therefore
chose to study BT_4507 and constructed a deletion mutant,
which lost resistance to ampicillin, further supporting the absence
of other significant b-lactamase activities (Table 2). For ease of
detection of b-lactamase activity, a B. thetaiotaomicron strain
was engineered to overexpress BT_4507. Overexpression of
BT_4507 in trans in the deleted mutant raised the MIC of ampicillin
to levels 32-fold higher than for the WT strain (Table 2). Moreover,
the b-lactamase activities measured in periplasmic protein
extracts of the different variants correlated with the level of resist-
ance to ampicillin (Table 2).
Identification of novel cepA-like chromosomal genes
encoding cephalosporinases in Bacteroides species
A BLASTP search of the BT_4507-encoded protein sequence against
the non-redundant protein database31 identified 273 sequences
with significant alignments (E value ≤1 e240 and a minimal num-
ber of 60 identical amino acids over the entire sequence length).
These protein sequences derived mainly from bacteria of the
Bacteroidetes phylum. Among them, CepA and CfxA are two
class-A cephalosporinase variants from B. fragilis32,33 and CblA is
a class A cephalosporinase from Bacteroides uniformis.34 A phylo-
genetic tree was constructed by alignment of nine Bacteroides
representatives (Figure 2), with two GES-type b-lactamases from
Enterobacteriaceae as an outgroup.35 BT_4507 belonged to the
Table 2. Resistance to ampicillin and related b-lactamase activity in B. thetaiotaomicron
Strain Genotypea MICb b-Lactamase activityc in the periplasm
b-Lactamase activityc associated with OMVsd
total activity vesicle fraction buffer
GH196 WT (pGH043) 32 269+8 33+6 29+5 ND
GH266 DBT_4507 (pGH043) 1 0.1+0.3 ND ND ND
GH274 DBT_4507 (pGH098) 1024 12415+551 284+14 271+11 2.3+0.5
ND, not detected.
apGH043, empty vector; pGH098, plasmid overexpressing BT_4507.
bConcentration of ampicillin in mg/L. The results are from two experiments performed independently.
cb-Lactamase activity expressed in nmol of hydrolysed nitrocefin/mg of protein/min. The activity was assessed spectrophotometrically by hydrolysis of
nitrocefin. The results shown are from three experiments performed independently.
dThe vesicles were incubated in phosphate buffer (0.1 M phosphate/1 mM EDTA, pH 7.0) for 1 h at 378C and the total activity in the suspension was
measured after sonication. Alternatively, the vesicles were removed by filtration and the activity was measured in the vesicle fraction and in the filtered
buffer.
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CepA clade, which includes CepA from B. fragilis. We shall therefore
refer to the BT_4507-encoded enzyme as BtCepA.
To test whether the cephalosporinase homologues from refer-
ence Bacteroides listed in the phylogenetic tree were b-lactamases,
we adapted two phenotypic confirmatory tests developed for
Enterobacteriaceae ESBLs to Bacteroides.36 Resistance to third-
generation cephalosporin antibiotics was measured and compared
in the presence and absence of clavulanic acid, which inhibits
class A b-lactamases (Table 1). Except for the B. thetaiotaomicron
cepAdeletion mutant, the zone size measured in the combined disc
method using cefpodoxime (10 mg) increased by .5 mm when
clavulanic acid (1 mg) was added. This result was confirmed
using a cefotaxime-based Etest method (Table 1). Therefore, all
Bacteroides tested contained at least one class A cephalosporinase
gene.
The cephalosporinase enzymes inferred to be the products of
these genes were isolated, purified and extensively characterized
from crude extracts of clinical isolates of B. thetaiotaomicron,
B. fragilis and Bacteroides vulgatus by Sato et al.37 three decades
ago. The susceptibility profile of B. thetaiotaomicron VPI-5482 is
unexceptional for a Bacteroides species, with susceptibility to car-
bapenems, co-amoxiclav and cefoxitin (data not shown), but
resistance to ampicillin, amoxicillin, cefotaxime and cefpodoxime.
B. thetaiotaomicron OMVs are naturally produced
and carry BtCepA on their surface
We recently established that the phosphatase BtMinpp is exported
and active in OMVs produced by B. thetaiotaomicron.21 However,
one of the first steps of the standard protocol used for OMV isola-
tion involves centrifugation of a bacterial culture in order to sep-
arate bacterial cells from the soluble fraction containing the
vesicles. This centrifugation can cause cell surface damage, giving
a potential for artefacts.38 Therefore, to ensure that OMVs isolated
after cell centrifugation are produced during bacterial cell growth
and are not derived from ruptured and damaged cells, we devel-
oped an alternative procedure in which OMVs were collected from
a growing bacterial culture after their diffusion through a mem-
brane filter into a compartment containing sterile medium (see
the Materials and methods section). The OMVs obtained were
visualized by electron microscopy (Figure 3a) and were indistin-
guishable from those generated by the standard centrifugation
protocol, confirming that they are produced by living cells and
not by, e.g. centrifugal shear forces.
We next addressed whether BtCepA is exported to OMVs.
Assessment of the b-lactamase activity in B. thetaiotaomicron
OMV protein extracts confirmed that BtCepA is associated with
OMVs (Table 2). To localize BtCepA, OMV preparations were treated
with proteinase K to digest any BtCepA associated with the outer
surface of the vesicles. Only 5 min of proteinase K treatment was
required for OMVs to lose 84% of their enzymatic activity when
compared with non-treated OMVs (Figure 3b). Control experi-
ments showed that activity of the BtMinpp phosphatase was
not affected by proteinase K, confirming its location inside the
vesicles. This result strongly suggests that a large fraction of
BtCepA is exposed on the surface of the vesicles.
To ensure that the b-lactamase activity measured in solutions
containing OMVs was not the result of enzyme release from OMVs
into the milieu, a control experiment was run using vesicles iso-
lated from B. thetaiotaomicron over-expressing BtCepA. No activ-
ity was detected in the milieu after 1 h of incubation (Table 2),
consistent with the degradation of exogenous b-lactam antibio-
tics by OMVs occurring primarily at their surface and to a lesser
extent within the vesicles.
Cephalosporinases are exported on the surface of OMVs
released by other Bacteroides species
Based on the results obtained with BtCepA, we anticipated that
cephalosporinases from other Bacteroides species would also be
(a)
(c)
(b)
Figure 1. Scanning electron microscope image of B. thetaiotaomicron
cells. (a) Non-treated cells. (b and c) Cells grown in the presence of
10 mg/L ampicillin. Scale bar, 10 mm (b) and 1 mm (a and c). The
nodes, likely to represent the site of cell septation, are indicated with
white arrows in (c).
E. coli (pHCG11) GES-type ESBL
K. oxytoca (pINCan01) GES-type ESBL
B. uniformis CblA
B. thetaiotaomicron CfxA
B. thetaiotaomicron BT_4507
B. stercoris BACSTE_01456
B. dorei BACDOR_02757
B. ovatus BACOV975_02528
B. xylanisolvens GIB_3495
B. fragilis CepA
B. fragilis BF_1199
100
100
100
55
0.5
54
100
86
100
100
Figure 2. Phylogenetic tree derived from the alignment of 11 b-lactamase
proteins from different bacterial species constructed using the maximum
likelihood method. To provide statistical support for each node on the tree,
a consensus tree was generated from 1000 bootstrap datasets. The tree is
drawn to scale, with branch lengths measured as the number of
substitutions per site. E., Escherichia; K., Klebsiella; B., Bacteroides; GES
enzymes are plasmid-mediated types that are disseminated among
Enterobacteriaceae.
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exported to OMVs. Accordingly, we investigated the capacity for
isolated vesicles from Bacteroides dorei, B. fragilis, Bacteroides ova-
tus, Bacteroides stercoris and Bacteroides xylanisolvens to degrade
b-lactam antibiotics present in the external milieu. OMVs were
incubated in the presence of the third-generation cephalosporin
cefotaxime and the degradation of the antibiotic was measured
by applying the antibiotic solution, once OMVs had been removed,
to a blank filter paper disc on a plate seeded with Salmonella as the
indicator organism (Figure 4). S. enterica serovar Typhimurium has
previously been used as an indicator strain in studies showing a
protective effect by ampicillin-resistant E. coli.7
OMVs from B. fragilis, B. stercoris and B. thetaiotaomicron
showed the highest capacity to degrade cefotaxime, with no vis-
ible inhibition of Salmonella growth remaining (Figure 4). In con-
trast, a zone of inhibition similar to that with untreated antibiotic
was observed with B. ovatusOMVs, indicating that nob-lactamase
activity was present in/on these OMVs despite expression of an
active cephalosporinase (Table 1). These data suggest that,
under laboratory conditions, the cephalosporinase produced by
B. ovatus may be excluded from OMVs, as previously shown for
various outer membrane proteins in E. coli,30 or, alternatively,
does not bind to the surface of OMVs.
Using the proteinase K procedure applied to B. thetaiotaomicron
OMVs (see above), 80%, 86% and 93% of the b-lactamase activity
is exposed on the surface of B. fragilis, B. stercoris and
B. xylanisolvens OMVs, respectively. The activity from B. dorei
OMVs was very weak, making evaluation of the surface-exposed
fraction difficult.
The clear reduction in the cefotaxime inhibition zone following
exposure to OMVs from most Bacteroides species strongly sug-
gests that these OMVs have the capability to serve as antibiotic
degradation machineries in the GI tract of animals, acting
remotely and independently of their parental bacterial cells.
B. thetaiotaomicron OMVs protect Salmonella
Typhimurium and B. breve against b-lactam antibiotics
To confirm that OMVs carrying cephalosporinases can protect
bacteria from b-lactam activity, B. thetaiotaomicron OMVs
were added to growing cultures of Salmonella Typhimurium
(Figure 5a) or to those of the human commensal intestinal bacter-
ium B. breve (Figure 5b) in the presence or absence of cefotaxime.
Vesicles produced by the DBtcepA deletion mutant were used as a
negative control. As expected, cefotaxime had a dramatic effect
on the viability of Salmonella Typhimurium cells when grown in
the presence of vesicles lacking BtcepA (Figure 5a). By contrast,
addition of BtCepA-loaded vesicles allowed the salmonellae to
grow normally in the presence of the lowest cefotaxime concen-
tration (1 mg/L) and at a slower rate for the highest concentration
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Figure 3. OMVs are produced in vivo by B. thetaiotaomicron and display
BtCepA on their surface. (a) Electron microscopic photograph of OMVs
collected from a sterile compartment after their diffusion through a
0.22 mm membrane from a compartment containing a B. thetaiotaomicron
culture (see the Materials and methods section). Scale bar, 100 nm.
(b) BtCepA and BtMinpp activities measured after treatment of OMVs with
proteinase K. The relative activity is the ratio of the activity measured after
proteinase K treatment compared with the activity measured without
treatment. Dark grey bars, no proteinase K pre-treatment; light grey bars,
proteinase K pre-treatment. *P,0.0001; **P¼0.69.
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Figure 4. OMVs produced by Bacteroides spp. degrade cefotaxime.
Antibiotic disc susceptibility test using Salmonella Typhimurium. The
discs were loaded with 10 mL of a 10 mg/L cefotaxime solution that had
been incubated for 1 h at 378C with OMVs from different Bacteroides
species. The discs were then placed onto Salmonella-inoculated agar
plates. The inhibition zones were read after 16 h of incubation at 378C.
Control, 0.1 mg cefotaxime.
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(10 mg/L). The same phenomenon was observed when ampicillin
was used (data not shown). Because of its slower growth rate,
B. breve appeared more resistant to cefotaxime than Salmonella
Typhimurium over time (Figure 5b). However, the presence of
B. thetaiotaomicron BtCepA-loaded vesicles in the medium
allowed the cells to grow until saturation of the culture at 24 h,
whereas most of the cells were killed after 24 h when the culture
was supplemented with DBtcepA vesicles. Thus, b-lactamase-
loaded OMVs from Bacteroides protected Salmonella Typhimurium
and B. breve against b-lactam antibiotics.
Discussion
Our study focuses on the identification of cephalosporinase genes
in human gut Bacteroides species and on the distribution of their
product. We find that, in addition to being secreted to the peri-
plasm of bacterial cells, these cephalosporinases also associate
with OMVs produced by these bacteria; the results are consistent
with a role for these OMVs in degrading b-lactam antibiotics
remotely from their parental cells.
Whereas Gram-positive b-lactamase-producing organisms
largely liberate their enzymes into the surrounding milieu, the
b-lactamases of Gram-negative bacteria are usually considered
to be confined to the periplasmic space of the cells, acting in con-
cert with the diffusion barrier of the outer membrane.39 The outer
membrane of E. coli constitutes a diffusion barrier for both peni-
cillins and cephalosporins;40 it thereby slows the influx of anti-
biotic molecules and is one of the major factors that determine
the degree of antibiotic resistance of the organism.41 In this
report, we show that part of cephalosporinase BtCepA becomes
associated with membrane vesicles and this BtCepA–OMV associ-
ation efficiently degrades substrate b-lactam antibiotics present
in the surrounding medium. The extracellular degradation of
b-lactam antibiotics is attributable to the OMVs only, since no
leakage of the enzyme into the medium could be detected
(Table 2). Degradation experiments with proteinase K showed
that BtCepA was exposed on the surface of the vesicles rather
than being sequestered within their lumen (Figure 3b). This is of
interest since surface-exposed enzymes, exposed to the full anti-
biotic concentration, can achieve swifter substrate turnover than
periplasmic enzymes in hydrolysing b-lactams in the surrounding
medium40 and, by extension, would be more efficient than
enzymes located inside OMVs.
Although our findings are consistent with a large fraction of
BtCepA being associated with the membrane of OMVs and being
exposed on the surface of the vesicles, no transmembrane region
was predicted in BtCepA using the TMHMM server (http://www.cbs.
dtu.dk/services/TMHMM-2.0/), suggesting that BtCepA is unlikely
to be embedded in the outer membrane. It is also unlikely that
BtCepA is a lipoprotein, since Bacteroides b-lactamases give dis-
crete and sharp bands by isoelectric focusing analysis,42 instead
of smearing, as expected for lipoproteins. BtCepA and other
Bacteroides cephalosporinases perhaps may electrostatically
associate with surface phosphates of vesicle phospholipids, but
further analysis of their exact localization and attachment is
needed, in both bacterial cells and OMVs, to confirm or refute
this hypothesis and to determine exactly how these proteins
anchor to the surface of OMVs.
It is well established that antibiotic usage strongly affects the
intestinal microbiota.2,43 For example, Pe´rez-Cobas et al.2 recently
reported that combined intravenous therapy with ampicillin/
sulbactam and cefazolin caused significant microbiota disturb-
ance in the human colon. Hence, we speculate that Bacteroides
species in the human GI tract microbiota have the potential to
protect Salmonella and possibly other pathogens and commensal
microorganisms, such as the probiotic B. breve, by yielding large
numbers of cephalosporinase-coated OMVs. More generally, the
presence of cephalosporinase-coated OMVs in the colon could
contribute to the maintenance of a balanced microbiota protect-
ing against the adverse effects of antibiotic treatments. It
remains unclear whether members of the genus have specifically
evolved to do this during the antibiotic era or whether, as seems
more likely, the association of these cephalosporins, which are
inherent to most members of the genus, and the OMVs is essen-
tially fortuitous. Notably, the B. fragilis NCTC 9343 strain, which
produces b-lactamase-coated vesicles, was deposited with a cul-
ture collection as early as 1955, suggesting that the behaviour is
not a very recent development.
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